Back to results
US 2026/0294802 A1Published application
Methods of treating central nervous system disorders with sublingual or buccal dosage forms comprising antioxidants
AssigneeBeyond Barriers Therapeutics, Inc.
InventorsRyan KOLE, John MARSHALL, Charles POLSKY, Brian REINHARDT, Thomas A. DEGREGORIS
Life of this patent
Estimating the term…
Abstract
Sublingual or buccal dosage forms comprise at least one antioxidant compound, such as N-acetyl cysteine (NAC), or a pharmaceutically acceptable salt thereof. The sublingual or buccal dosage forms are administered for treating central nervous system (CNS) disorders, such as traumatic brain injury or stroke.
Claims21
A method of treating a central nervous system (CNS) disorder, the method comprising sublingually or buccally administering to a subject an effective amount of an antioxidant compound or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.